3 stellar ASX growth shares to buy

ResMed Inc. (ASX:RMD) and these ASX growth shares could be top options for growth investors right now. Here's why…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australian share market is home to a large number of companies that have been growing at a strong rate in recent years.

Three that have been tipped to continue this positive form are listed below. Here's why they could be top options for growth investors:

Surge in ASX share price represented by happy woman pointing to her big smile

Image source: Getty Images

Appen Ltd (ASX: APX)

Appen is a leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI). It has team of over a million contractors spread out across the world preparing or creating the data for the machine learning models of some of the world's largest companies and government agencies. Due to favourable industry tailwinds, analysts at Morgan Stanley believe it has strong long term growth potential. They recently put an overweight rating and $40.00 price target on its shares.

NEXTDC Ltd (ASX: NXT)

NEXTDC is one of the region's leading data centre operators. It has been delivering strong revenue and operating earnings growth in recent years thanks to increasing demand for capacity in its centres. The catalyst for this has been the structural shift to the cloud, which has accelerated during the pandemic. One broker that is very positive on its future is Goldman Sachs. It recently reiterated its buy rating and $13.20 price target on its shares. The broker even suggested the NEXTDC share price could go to $20.00 based on high but not unrealistic assumptions.

ResMed Inc. (ASX: RMD)

ResMed is a medical device company which has been growing at a consistently strong rate over the last decade. This has been underpinned by its industry-leading sleep treatment products and its growing market opportunity. Pleasingly for shareholders, its market is still growing strongly. Management believes there are upwards of a billion people suffering from sleep apnoea globally. As more and more become aware of the disorder and seek treatment, the company is in a strong position to benefit. Analysts at Morgans are positive on its outlook. They have an add rating and $30.99 price target on its shares.

James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Appen Ltd. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Growth Shares

2 under-the-radar ASX shares with bags of potential

It could be worth getting better acquainted with these shares.

Read more »

Happy man working on his laptop.
Growth Shares

Brokers rate these 3 top ASX shares as buys in April

Experts are optimistic about what these businesses can achieve.

Read more »

a man wearing casual clothes fans a selection of Australian banknotes over his chin with an excited, widemouthed expression on his face.
Growth Shares

3 ASX shares that could double over the next decade (or much sooner)

These shares could be positioned to deliver strong returns in the future. Let's find out why.

Read more »

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »